ERNA
Price:
$1.31
Market Cap:
$10.28M
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Industry
Biotechnology
IPO Date
1991-08-29
Stock Exchange
NASDAQ
Ticker
ERNA
According to Ernexa Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.79M. This represents a change of -91.83% compared to the average of 95.34M of the last 4 quarters.
The mean historical Enterprise Value of Ernexa Therapeutics Inc. over the last ten years is 627.06M. The current 7.79M Enterprise Value has changed 24.18% with respect to the historical average. Over the past ten years (40 quarters), ERNA's Enterprise Value was at its highest in in the June 2021 quarter at 11.42B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
627.06M
Median
166.99M
Minimum
79.85M
Maximum
2.69B
Discovering the peaks and valleys of Ernexa Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.29%
Maximum Annual Enterprise Value = 2.69B
Minimum Annual Increase = -94.80%
Minimum Annual Enterprise Value = 79.85M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 124.19M | -30.13% |
| 2023 | 177.75M | 26.91% |
| 2022 | 140.06M | -94.80% |
| 2021 | 2.69B | 15.62% |
| 2020 | 2.33B | 2.29% |
| 2019 | 97.70M | 22.34% |
| 2018 | 79.85M | -48.89% |
| 2017 | 156.24M | -36.35% |
| 2016 | 245.47M | 9.11% |
The current Enterprise Value of Ernexa Therapeutics Inc. (ERNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
147.33M
5-year avg
1.09B
10-year avg
627.06M
Ernexa Therapeutics Inc.’s Enterprise Value is less than Adaptimmune Therapeutics plc (97.78M), less than MapLight Therapeutics, Inc. (0), less than Lunai Bioworks Inc. (33.22M), greater than ProMIS Neurosciences, Inc. (-5422421.00), greater than Dogwood Therapeutics, Inc. (1.78M), greater than BiomX Inc. (5.96M), greater than Moleculin Biotech, Inc. (3.01M), less than AEON Biopharma, Inc. (20.80M), less than OSR Holdings, Inc. (15.64M), greater than Aethlon Medical, Inc. (-3180829199.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 97.78M | $75.16M | |
| 0 | $14.48M | |
| 33.22M | $23.14M | |
| -5422421.00 | $9.98M | |
| 1.78M | $11.73M | |
| 5.96M | $7.28M | |
| 3.01M | $9.32M | |
| 20.80M | $8.72M | |
| 15.64M | $17.76M | |
| -3180829199.00 | $10.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ernexa Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ernexa Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ernexa Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ernexa Therapeutics Inc. (ERNA)?
What is the 3-year average Enterprise Value for Ernexa Therapeutics Inc. (ERNA)?
What is the 5-year average Enterprise Value for Ernexa Therapeutics Inc. (ERNA)?
How does the current Enterprise Value for Ernexa Therapeutics Inc. (ERNA) compare to its historical average?